EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Advances in Transdermal Drug Delivery: Formulation and Application

Dr. John Doe

American Journal of Pharmaceutics · 2020-06-30 · 1 (3) · 1-11

DOI: 10.71465/ajph1872 ↗

At a glance

Journal article in American Journal of Pharmaceutics, published online on 2020-06-30. Written by Dr. John Doe. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Transdermal drug delivery (TDD) systems offer a unique approach to the administration of therapeutic agents through the skin. This delivery method provides numerous benefits over traditional oral and injectable routes, including improved patient compliance, controlled drug release, and minimal side effects. Recent advancements in transdermal formulations, including the use of nanotechnology, microneedles, and permeation enhancers, have significantly improved the efficacy and safety of these systems. This article reviews the current state of transdermal drug delivery, exploring the latest formulations, applications, challenges, and future directions in the field.

Cite

APA

Doe, D. J. (2020). Advances in Transdermal Drug Delivery: Formulation and Application. American Journal of Pharmaceutics, 1(3), 1-11. https://doi.org/10.71465/ajph1872

Vancouver

Doe DJ. Advances in Transdermal Drug Delivery: Formulation and Application. American Journal of Pharmaceutics. 2020;1(3):1-11. doi:10.71465/ajph1872

BibTeX
@article{Doe2020,
  author = {Doe, Dr. John},
  title = {Advances in Transdermal Drug Delivery: Formulation and Application},
  journal = {American Journal of Pharmaceutics},
  year = {2020},
  volume = {1},
  number = {3},
  pages = {1--11},
  doi = {10.71465/ajph1872}
}
Start for free →